U.S. stocks’ amazing run in 2013 raises the stakes for next year. Will markets keep rising, powered by steady economic growth and low interest rates, or will they take a breather after the Federal Reserve begins paring back economic stimulus?
That is the question on the minds of bullish and bearish investors alike as the year winds down. Friday’s 1.3% gain in the Dow Jones Industrial Average following a positive employment report left money managers hoping for a strong finish to what so far is the best year for stocks in a decade. The Dow is up 22%.
History seems to support the idea that 2014 will be less historic than 2013. Since 1927, there have been 23 years in which the S&P 500 has risen 20% or more, according to Birinyi Associates. It averaged a further gain of 6.4% in the next year. That is only slightly better than the 5.5% gain the S&P averaged for all years since 1927.
Top 10 Electric Utility Stocks To Invest In Right Now: Samsung Electronics Co Ltd (SSNLF.PK)
Samsung Electronics Co., Ltd. mainly engaged in the production of consumer electronic products. It operates in two divisions: DMC division, which is divided into consumer electronics (CE) and information technology & mobile communications (IM) businesses, as well as DS division, which is divided into semiconductor and liquid crystal display (LCD) businesses. Its CE business engages in the production of color televisions (CTVs), monitors, air conditioners, refrigerators and others. Its IM business engages in the production of printers, computers, handhold phones (HHPs) such as feature phones, smart phones and others, and network systems, among others. Its semiconductor business engages in the production of semiconductors, such as memories, system large scale integrated circuits (LSIs) and others. Its LCD business engages in the production of thin film transistor (TFT) LCDs and organic light-emitting diodes (OLEDs), among others.
Advisors' Opinion:- [By George Kesarios]
So in the prepaid market, surprisingly enough, Apple has actually scored points, despite the fact that it's a high-end high priced device maker. LG however is probably the biggest winner, because NPD tells us it doubled its market share, while Samsung (SSNLF.PK) has remained in the number one position having retained its market share. The biggest surprise of all however is that Nokia (NOK) is not on this list.
Top 10 Healthcare Technology Stocks To Invest In 2014: Avista Corporation (AVA)
Avista Corporation, an energy company, engages in the generation, transmission, and distribution of energy and other energy-related businesses in the United States and Canada. It operates in two segments, Avista Utilities and Advantage IQ. The Avista Utilities segment involves in the generation, transmission, and distribution of electricity primarily from hydroelectric and thermal sources. It also engages in the distribution of natural gas to retail customers in eastern Washington, northern Idaho, and parts of northeast and southwest Oregon, as well as in the wholesale purchase and sale of electricity and natural gas. As of December 31, 2010, this segment operated facilities with a total net capability of 1,791 mega watts, as well as provided retail electric service to 359,000 customers; and retail natural gas service to 319,000 customers. This segment offers electricity and natural gas to residential, commercial, and industrial customers. The Advantage IQ segment provides sustainable utility expense management and energy management solutions to multi-site companies in North America. It offers invoice processing, auditing and payment services, energy procurement, reporting, advanced analysis, and consulting services. In addition, the company engages in the custom sheet metal fabrication of electronic enclosures, parts, and systems for the computer, telecom, renewable energy, and medical industries; real estate investments, primarily commercial office buildings; and investing in emerging technology venture capital funds and low income housing. Avista Corporation was founded in 1889 and is headquartered in Spokane, Washington.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Avista (NYSE: AVA ) , whose recent revenue and earnings are plotted below. - [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Avista (NYSE: AVA ) , whose recent revenue and earnings are plotted below. - [By Dividends4Life]
Starting in 2013 the federal tax rates on qualified dividends are 0%, 15% and 20%. The 20% rate is for taxpayers in the 39.6% tax bracket. For those in the 10% and 15% brackets, there is no tax on qualified dividends. In contrast, ordinary income is taxed at rates up to up to 39.6%. Below are several stocks that have consistently paid dividends through depressions, recessions, world wars, and other political and economic upheavals:WGL Holdings Inc. (WGL) provides natural gas service in the Washington, DC, metropolitan area and surrounding regions, including Maryland and Virginia. Yield: 4.1% | Paid Dividends Since: 1852Exxon Mobil Corp. (XOM), formed through the merger of Exxon and Mobil in late 1999, is the world's largest publicly owned integrated oil company. Yield: 2.7% | Paid Dividends Since: 1882Consolidated Edison, Inc. (ED) is an electric and gas utility holding company serves parts of New York, New Jersey and Pennsylvania. Yield: 4.4% | Paid Dividends Since: 1885The Procter & Gamble Company (PG) is a leading consumer products company that markets household and personal care products in more than 180 countries. Yield: 3.2% | Paid Dividends Since: 1891The Coca-Cola Company (KO) is the world's largest soft drink company, KO also has a sizable fruit juice business. Yield: 2.9% | Paid Dividends Since: 1893General Mills, Inc. (GIS) is a major producer of packaged consumer food products, include cereal, yogurt and Betty Crocker desserts/baking mixes. Yield: 3.0% | Paid Dividends Since: 1898Avista Corp. (AVA) generates, transmits and distributes energy as well as engages in energy-related businesses in the United States and Canada. Yield: 3.0% | Paid Dividends Since: 1899MGE Energy Inc. (MGEE) is a public utility holding company that supplies electric service to apx. 140,000 customers; and natural gas service to apx. 145,000 customers in Wisconsin (as of December 2012). Yield: 2.8% | Paid Dividends Since: 1909Xcel Energy Inc. (XEL) offers energy-related prod
Top 10 Healthcare Technology Stocks To Invest In 2014: S&P 500/Barra Value(SU)
Suncor Energy Inc., together with its subsidiaries, operates as an integrated energy company. The company involves in the development of petroleum resource basins in Canada's Athabasca oil sands; acquisition, exploration, development, production, and marketing of crude oil and natural gas in Canada and internationally; transportation and refining of crude oil; and marketing of petroleum and petrochemical products primarily in Canada. Its Oil Sands segment produces bitumen recovered from oil sands through mining and in-situ technology, and upgrades it into refinery feedstock, diesel fuel, and by-products. This segment?s products include gasoline and distillates. The company?s Natural Gas segment acquires, explores, develops, and produces natural gas, natural gas liquids, oil, and by-products from reserves located primarily in western Canada, the Northwest Territories, Alaska, and the Arctic Islands. Its International and Offshore segment engages in the exploration and pro duction of oil and gas in offshore Newfoundland and Labrador, in the North Sea, and in Libya and Syria. The company?s Refining and Marketing segment refines crude oil at Suncor's refineries in Edmonton, Alberta; Montreal, Quebec; and Sarnia, Ontario in Canada, as well as in Commerce City, Colorado into a range of petroleum and petrochemical products for sale to retail, commercial, and industrial customers. It also transports crude oil through pipelines in eastern and western Canada, as well as through wholly-owned pipelines in Wyoming and Colorado; and produces specialty lubricants and waxes. In addition, this segment operates retail sites in Canada under the Petro-Canada brand; and in Colorado under Phillips 66 and Shell brands. Suncor Energy Inc. also engages in third-party energy trading activities. The company was formerly known as Suncor Inc. and changed its name to Suncor Energy Inc. in April 1997. Suncor Energy Inc. was founded in 1953 and is headquartered in Calgary , Canada.
Advisors' Opinion:- [By Jonathan Yates]
As to be expected, the share price has drifted down from the peak after the bullish activity. But long term investors should take note of the resources owned by Octagon 88. Canadian energy assets have drawn "Big Oil" from around the world such as CNOOC (NYSE: CEO) and Chevron (NYSE: CVX). In addition, Suncor Energy (NYSE: SU), a major oil firm based in Canada, has Warren Buffett gobbling up its shares.
- [By Dan Caplinger]
At the same time, though, Total has been smart about not wasting its financial resources. It sold off its minority stake in one major venture in the Canadian oil sands to partner Suncor Energy (NYSE: SU ) in May, taking a $1.65 billion charge but saving $5 billion in prospective costs. Suncor also abandoned the Voyageur project, validating Total's decision.
- [By Tyler Crowe]
What a Fool believes
When Suncor (NYSE: SU ) , the largest producer of oil sands, is shelving oil sands projects, you know it's hard to make a Loonie in the Canadian oil sands business right now. For investors, there has been very little love on this roller coaster as of late. Hopefully, regions like the Utica will be a good luck charm and will help to resolve some of the operational woes for the region. Then all oil sands advocates will need to do is deal with is find a market that will buy its product. Gulp.
Top 10 Healthcare Technology Stocks To Invest In 2014: Salix Pharmaceuticals Ltd (SLXP)
Salix Pharmaceuticals, Ltd., incorporated on December 31, 2001, is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract. As of December 31, 2012, the Company�� products included XIFAXAN, MOVIPREP, APRISO, RELISTOR, OSMOPREP, SOLESTA, DEFLUX, FULYZAQ, GIAZO, METOZOLV ODT, AZASAN, ANUSOL-HC, PROCTOCORT, PEPCID, DIURIL and COLAZAL. As of December 31, 2012, its primary product candidates under development included Rifaximin, Methylnaltrexone bromide oral, Budesonide foam and Rifaximin EIR. In January 2014, Salix Pharmaceuticals, Ltd. acquired Santarus, Inc.
Xifaxan (rifaximin) tablets
Xifaxan is a gastrointestinal-specific oral antibiotic. The Food and Drug Administration ( FDA) approved Xifaxan 200 milligram for the treatment of patients 12 years of age and older with travelers��diarrhea caused by noninvasive strains of E coli. Xifaxan 550 milligram was approved by the FDA for reduction in risk of overt hepatic encephalopathy (HE), recurrence in patients 18 years of age or older.
It launched Xifaxan 200milligram in the United States and Xifaxan 550 milligram using its own direct sales force. The Company is exploring potential additional indications, formulations, clinical trials and co-promotion arrangements to capitalize on the potential for Xifaxan, including its development program in irritable bowel syndrome.
In October 2012, the USPTO declared an interference action to determine the priority of invention between Cipla�� application related to amorphous rifaximin and Solmag SpA�� application directed to amorphous rifaximin. In February 2012, the FDA posted draft bioequivalence guidance for rifaximin 550 milligram tablets. The draft guidance for rifaximin 550 milligram tablets recommends that in addition to conducting the program outlined in the FDA posted ! draft guidance document for rifaximin 200 milligram tablets discussed above, a single-dose, three-way crossover in-vivo study of fasting bioequivalence with pharmacokinetic endpoints in both fasting and fed states be performed in the 550 milligram tablets. Additionally, the guidance stipulated that the formulation of the 550 milligram strength should be proportionally similar to that of the 200 milligram strength in order to file an ANDA for approval of a generic rifaximin 550 milligram tablet for the treatment of hepatic encephalopathy.
MoviPrep (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid) oral solution
MoviPrep is a patent-protected, liquid polyethylene glycol-salt, or PEG, bowel cleansing product that the FDA approved. MoviPrep is indicated for bowel cleansing prior to colonoscopy, intestinal surgery and barium enema X-ray examinations.
Apriso (mesalamine) extended-release capsules 0.375 gram
Apriso is a locally-acting aminosalicylate and is the only delayed and extended release mesalamine product approved by the FDA for once-a-day dosing for the maintenance of remission of ulcerative colitis. Apriso is designed to provide for the distribution of the active ingredient beginning in the small bowel and continuing throughout the colon. The product�� prolonged release mechanism might allow them to expand the range of treatment options for ulcerative colitis.
Relistor (methylnaltrexone bromide)
Relistor Subcutaneous Injection is indicated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient. Relistor is approved for use in over 55 countries worldwide.
OsmoPrep and Visicol (sodium phosphate monobasic monohydrate, USP, sodium phosphate dibasic anhydrous, USP) tablets
Visicol and OsmoPrep tablets are indicated for clean! sing of t! he colon as a preparation for colonoscopy in adults 18 years of age or older. Visicol and OsmoPrep are the only, tablet bowel cleansing products approved by the FDA and marketed in the United States. OsmoPrep is a patented, second-generation tablet bowel cleansing product that the FDA approved. OsmoPrep offers potential benefits compared to Visico,l such as its lack of microcrystalline cellulose, smaller tablet size and possible lower dose administration.
Solesta
Solesta is a biocompatible tissue bulking agent, consisting of dextranomer microspheres and stabilized sodium hyaluronate. Solesta is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy, such as diet, fiber therapy and/or anti-motility medications. It is the only injectable gel for this indication to be administered in an outpatient setting without the need for surgery or anesthesia.
Deflux
Deflux is a medical device indicated for children affected by Grades II-IV vesicoureteral reflux, a malformation of the urinary bladder that can result in severe infections of the kidneys and irreversible kidney damage. Deflux was granted premarket approval application (PMA) approval, and has been on the market in the United States.
Fulyzaq (crofelemer) delayed-release tablets
On December 31, 2012, the FDA granted marketing approval for this product, under the trade name Fulyzaq. Fulyzaq is indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy. Fulyzaq should also be eligible for five years of marketing exclusivity from the date of FDA approval, and the product might be entitled to patent term restoration.
Giazo (balsalazide disodium) tablets
February 3, 2012, the FDA granted marketing approval for this product under the trade name Giazo. Giazo is indicated for the treatment of mildly to moderately active ulcerative col! itis in m! ale patients 18 years of age and older. It shipped Giazo to wholesalers in 2012.
Metozolv ODT (metoclopramide hydrochloride) 5 milligrams and 10 milligrams orally disintegrating tablets
METOZOLV ODT is indicated for the relief of symptomatic gastroesophageal reflux or short-term (4-12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy and diabetic gastroparesis or the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis.
Azasan (azathioprine) tablets
Azasan is an FDA-approved drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. It launched the 75 and 100 milligrams dosage strengths of Azasan in the United States.
Anusol-HC and Proctocort (hydrocortisone) creams and suppositories
The Company acquired the right to sell Anusol-HC 2.5% (hydrocortisone USP) cream, Anusol-HC 25 milligrams (hydrocortisone acetate) rectal suppositories, Proctocort 1% (hydrocortisone USP) cream and Proctocort 30 mg (hydrocortisone acetate) rectal suppositories from King Pharmaceuticals, Inc. The two cream products are topical corticosteroids indicated for relief of the inflammatory and pruritic, or itching, manifestations of corticosteroid-responsive dermatoses. The two suppository products are indicated for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and other inflammatory conditions.
Pepcid (famotidine) for Oral Suspension and Diuril (Chlorothiazide)
Pepcid Oral Suspension is a widely known prescription pharmaceutical product indicated for several gastrointestinal indications, including the treatment of duodenal ulcer, benign gastric ulcer and gastro-esophageal reflux disease. Pepcid Oral Suspension and Diuril Oral Suspension, both liquid form! ulations ! of their solid dosage form counterparts, compete in a combined annual United States market concentrated in pediatric and hospitalized patient populations.
Colazal (balsalazide disodium) capsules
The Company launched Colazal to physicians in the United States. FDA approved Colazal for use in pediatric patients between 5 to 17 years of age with ulcerative colitis. The pediatric use of Colazal has been granted orphan drug designation. The Office of Generic Drugs, or OGD, approved three generic balsalazide capsule products.
The Company competes with GlaxoSmithKline plc, Giuliani S.p.A., Axcan Pharma, Inc., Abbott Laboratories, Warner Chilcott plc, Shire Pharmaceuticals Group plc, Pharmacia & Upjohn, Inc., Alaven Pharmaceutical LLC, Ferring Pharmaceuticals, Inc, Takeda Pharmaceutical Company Limited, Cumberland Pharmaceuticals, Inc, Prometheus Laboratories, Inc., Ranbaxy Pharmaceuticals, Ferndale Laboratories, GATE Pharmaceuticals , Nycomed , Medtronic, Inc., and Cubist Pharmaceuticals, Inc.
Advisors' Opinion:- [By Ben Levisohn]
Salix Pharmaceuticals (SLXP) has jumped 5.9% to $160� on reports it was in talk to sell itself to Actavis (ACT). It was also upgraded to Neutral from Underperform at Credit Suisse.
- [By Anna Prior]
A U.S. Food and Drug Administration office has approved Salix Pharmaceuticals Ltd.'s(SLXP) appeal to gain approval for expanded usage of a constipation drug it licensed from Progenics Pharmaceuticals Inc.(PGNX), the companies said. Shares of Progenics climbed 12% to $4.75 premarket.
- [By Jake L'Ecuyer]
Equities Trading UP
Santarus (NASDAQ: SNTS) shot up 37.95 percent to $32.03 after Salix Pharmaceuticals (NASDAQ: SLXP) announced its plans to buy Santarus for around $2.12 billion. Santarus and Pharming also announced new data from open-label repeat treatment study with RUCONEST.
Top 10 Healthcare Technology Stocks To Invest In 2014: Plug Power Inc.(PLUG)
Plug Power Inc., an alternative energy technology provider, involves in the design, development, commercialization, and manufacture of fuel cell systems for the industrial off-road markets and stationary power markets worldwide. It develops and sells a range of fuel cell systems comprising hydrogen-fueled Proton Exchange Membrane (PEM) systems. The company?s product line includes PEM GenDrive power unit for sale on commercial terms for industrial off-road consisting of forklift or material handling applications, with a focus on multi-shift high volume manufacturing and high throughput distribution sites. It sells its products to business, industrial, and government customers through direct product sales force, original equipment manufacturers, and their dealer networks. The company was founded in 1997 and is headquartered in Latham, New York.
Advisors' Opinion:- [By Paul Ausick]
Peers Plug Power Inc. (NASDAQ: PLUG), Ballard Power Systems Inc. (NASDAQ: BLDP), and Hydrogenics Corp. (NASDAQ: HYGS) have also shared in the stock price run-up. Any investor expecting more from FuelCell�� results was, perhaps, being irrationally exuberant.
- [By John Udovich]
Despite horrendous losses for investors over the long term, small cap fuel cell stocks FuelCell Energy Inc (NASDAQ: FCEL) and Plug Power Inc (NASDAQ: PLUG) have both made gains this year. However, which is the better small cap fuel cell stock for investors moving forward or should you just ignore both?
- [By Ben Levisohn]
Plug Power (PLUG) has risen 1.6% to $4.48 after the company said it had shipped more than 850 fuel cells in the third quarter.
JC Penney (JCP) has fallen 1.3% to $7.54 after the beaten-down retailer was cut to Sell from Hold at Maxim Group.
Top 10 Healthcare Technology Stocks To Invest In 2014: Wynn Resorts Limited(WYNN)
Wynn Resorts, Limited, together with its subsidiaries, engages in the development, ownership, and operation of destination casino resorts. The company owns and operates Wynn Las Vegas casino resort in Las Vegas, which includes approximately 22 food and beverage outlets comprising 5 dining restaurants; 2 nightclubs; 1 spa and salon; 1 Ferrari and Maserati automobile dealership; wedding chapels; an 18-hole golf course; meeting space; and foot retail promenade featuring boutiques. Wynn Las Vegas casino resort also features approximately 147 table games, 1 baccarat salon, private VIP gaming rooms, 1 poker room, 1,842 slot machines, and 1 race and sports book. It also owns and operates an Encore at Wynn Las Vegas resort, a destination casino resort located adjacent to Wynn Las Vegas that features a 2,034 all-suite hotel, as well as a casino with 95 table games, 1 sky casino, 1 baccarat salon, private VIP gaming rooms, and 778 slot machines. In addition, the company operates Wyn n Macau casino resort located in the Macau Special Administrative Region of the People?s Republic of China. Wynn Macau casino resort features approximately 595 hotel rooms and suites, 410 table games, 935 slot machines, 1 poker room, 1 sky casino, 6 restaurants, 1 spa and salon, lounges, meeting facilities, and retail space featuring boutiques. Further, it operates Encore at Wynn Macau resort located adjacent to Wynn Macau. Encore at Wynn Macau resort features approximately 410 luxury suites and 4 villas, as well as casino gaming space, including a sky casino consisting of 60 table games and 80 slot machines, 2 restaurants, 1 luxury spa, and retail space. The company was founded in 2002 and is based in Las Vegas, Nevada.
Advisors' Opinion:- [By Matt Thalman]
While Las Vegas Sands (NYSE: LVS ) and Wynn Resorts (NASDAQ: WYNN ) are both major players in Macau, MGM Resorts (NYSE: MGM ) is making a big push to grow its base in the Chinese gambling mecca, while it also has a massive footprint in Las Vegas, and the other two have a much lower room count. MGM owns a good portion of the Las Vegas Strip, and as we continue to see average daily hotel room rates rise for the city and increased gaming revenue for the strip, we will see MGM greatly benefit from a recovering American tourist industry and a stronger Las Vegas.
- [By Travis Hoium]
Any thought that the Las Vegas gaming market would recover quickly after the recession has long since been lost, but there is a slow and steady recovery taking place in Sin City. High-end operators Las Vegas Sands (NYSE: LVS ) and Wynn Resorts (NASDAQ: WYNN ) have been seeing improved results as wealthy customers return to the casinos, but the lower end of the market, where MGM Resorts (NYSE: MGM ) and Caesars Entertainment (NASDAQ: CZR ) play, has been choppy to say the least.
Top 10 Healthcare Technology Stocks To Invest In 2014: ESSA Bancorp Inc. (ESSA)
ESSA Bancorp, Inc. operates as the holding company for ESSA Bank & Trust that provides a range of financial services to individuals, families, and businesses in Pennsylvania. The company provides deposit accounts comprising savings accounts, NOW accounts, checking accounts, money market accounts, club accounts, certificates of deposit, IRAs, and other qualified plan accounts, as well as commercial checking accounts for businesses. It also offers residential first mortgage loans, including one-to-four family residential loans and construction mortgage loans; commercial real estate loans; home equity loans and lines of credit; and commercial and consumer loans, as well as various unsecured or secured loans, loans secured by deposits, personal loans, and automobile loans. In addition, the company provides asset management and trust services, and investment services, as well as insurance benefit consulting services, including health insurance, life insurance, short term and lo ng term disability, dental, vision, and 401(K) retirement planning, as well as individual health products. As of September 30, 2013, it operated 26 full-service banking offices, including 13 offices in Monroe County, 6 offices in Lehigh County, and 7 offices in Northampton County in Pennsylvania. The company was founded in 1916 and is based in Stroudsburg, Pennsylvania.
Advisors' Opinion:- [By Tim Melvin]
Right now I know that silver miners like Pan American Silver (PAAS) and Coeur Mining (CDE) are very cheap on an asset basis. I know that oil and gas producers like Swift Energy (SFY) and WPX Energy (WPX) are priced as if no one will ever use the stuff again. I know that small banks like Cape Bancorp (CBNJ) and Essa Bancorp (ESSA) are crazy-cheap — and if the world does not end, those stocks will be a lot higher in a few years.
- [By Tim Melvin]
I get somewhat amused every day by the thousands of traders who spend all day trying to figure out what the hot stocks like Twitter (TWTR) and Facebook (FB) are going to do every day. Owning stocks like these two banks — or ones I have mentioned before, like ESSA Bancorp (ESSA) and Charter Financial (CHFN) — will be a far more profitable and relaxing endeavor over the next few years.
No comments:
Post a Comment